Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat

被引:104
作者
Shirayama, Y
Mitsushio, H
Takashima, M
Ichikawa, H
Takahashi, K
机构
[1] NCNP,NATL INST NEUROSCI,DIV MENTAL DISORDER RES,KODAIRA,TOKYO 187,JAPAN
[2] NCNP,NATL CTR HOSP MENTAL NERVOUS & MUSCULAR DISORDERS,DEPT PSYCHIAT,KODAIRA,TOKYO 187,JAPAN
关键词
substance P; antidepressant; amygdala; striatum; substantia nigra;
D O I
10.1016/S0006-8993(96)00812-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated the effects of chronic treatment with food containing one of five antidepressants on substance P(SP) content in the rat brain using radioimmunoassay and enzyme-immunoassay. The antidepressants used were imipramine, desipramine, clomipramine, amoxapine and mianserin. Following 40 days of treatment, all the antidepressants decreased SP concentrations in the striatum, substantia nigra and amygdala. Only imipramine and desipramine reduced the peptide content in the hippocampus, and only mianserin reduced it in the septum. We further examined the acute effects of antidepressants one hour after a single intraperitoneal administration. Acute imipramine and desipramine treatment reduced SP in the striatum, whereas acute mianserin decreased it in the striatum and substantia nigra. These results demonstrate that all antidepressants on chronic treatment had a common effect, a reduction of SP content in the striatum, substantia nigra and amygdala. This raises the possibility that such a decrease may contribute to the therapeutic action of antidepressants in affective disorders.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 37 条
[1]   EXTRAHYPOPHYSEAL DISTRIBUTION OF ALPHA-MELANOCYTE STIMULATING HORMONE (ALPHA-MSH)-LIKE IMMUNOREACTIVITY IN POSTMORTEM BRAINS FROM NORMAL SUBJECTS AND ALZHEIMER-TYPE DEMENTIA PATIENTS [J].
ARAI, H ;
MOROJI, T ;
KOSAKA, K ;
IIZUKA, R .
BRAIN RESEARCH, 1986, 377 (02) :305-310
[2]  
ARORA RC, 1989, AM J PSYCHIAT, V146, P730
[3]  
BALLENGER JC, 1980, AM J PSYCHIAT, V137, P782
[4]   STRIATAL TACHYKININ BIOSYNTHESIS - REGULATION OF MESSENGER-RNA AND PEPTIDE LEVELS BY DOPAMINE AGONISTS AND ANTAGONISTS [J].
BANNON, MJ ;
ELLIOTT, PJ ;
BUNNEY, EB .
MOLECULAR BRAIN RESEARCH, 1987, 3 (01) :31-37
[5]  
BARBACCIA ML, 1986, J PHARMACOL EXP THER, V236, P307
[6]   PERTURBATION OF RAT-BRAIN SEROTONERGIC SYSTEMS RESULTS IN AN INVERSE RELATION BETWEEN SUBSTANCE-P AND SEROTONIN CONCENTRATIONS MEASURED IN DISCRETE NUCLEI [J].
BARDEN, N ;
DAIGLE, M ;
PICARD, V ;
DIPAOLO, T .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (03) :834-840
[7]   REGIONALLY SELECTIVE INCREASES IN BETA-ADRENERGIC-RECEPTOR DENSITY IN THE BRAINS OF SUICIDE VICTIMS [J].
BIEGON, A ;
ISRAELI, M .
BRAIN RESEARCH, 1988, 442 (01) :199-203
[8]   EFFECTS OF SUBCHRONIC TREATMENT WITH IMIPRAMINE, ZIMELIDINE AND ALAPROCLATE ON REGIONAL TISSUE-LEVELS OF SUBSTANCE P-LIKE AND NEUROKININ-A NEUROKININ B-LIKE IMMUNOREACTIVITY IN THE BRAIN AND SPINAL-CORD OF THE RAT [J].
BRODIN, E ;
OGREN, SO ;
THEODORSSONNORHEIM, E .
NEUROPHARMACOLOGY, 1987, 26 (06) :581-590
[9]   CLOMIPRAMINE AND CLONAZEPAM INCREASE CHOLECYSTOKININ LEVELS IN RAT VENTRAL TEGMENTAL AREA AND LIMBIC REGIONS [J].
BRODIN, K ;
OGREN, SO ;
BRODIN, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (1-2) :175-180
[10]  
CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1160